06-1746. Memorandum of Understanding Between the United States Food and Drug Administration and the United States General Services Administration  

  • Start Preamble

    AGENCY:

    Food and Drug Administration, HHS.

    ACTION:

    Notice.

    SUMMARY:

    The Food and Drug Administration (FDA) is providing notice of a memorandum of understanding (MOU) between the U.S. Food and Drug Administration and the U.S. General Services Administration (GSA) (collectively the Parties or individually a Party). The purpose of this MOU is to set forth an agreement between GSA and FDA regarding the roles, responsibilities, and financial commitments of each Party relating to FDA's agreement to coordinate, with GSA and its contractors, removal of a mercury-contaminated laboratory waste plumbing system; and GSA's agreement to coordinate, with FDA and its contractors, its scheduled hazmat removal and demolition work at Federal Office Building 8. It is the Parties' mutual desire to accomplish both actions in such a manner that controls and reduces the overall cost to the taxpayer.

    DATES:

    The agreement became effective January 9, 2006.

    Start Further Info

    FOR FURTHER INFORMATION CONTACT:

    For FDA: Kathleen Heuer, Office of the Commissioner (HF-20), Food and Drug Administration, 5600 Fishers Lane, rm. 14-57, Rockville, MD 20857, 301-255-6762.

    For GSA: William Guerin, U.S. General Services Administration, 301 Seventh St. SW., rm. 70-80, Washington, DC 20407, 202-708-5891.

    Start Printed Page 9569 End Further Info End Preamble Start Supplemental Information

    SUPPLEMENTARY INFORMATION:

    In accordance with 21 CFR 20.108(c), which states that all written agreements and MOUs between FDA and others shall be published in the Federal Register, the agency is publishing notice of this MOU.

    Start Signature

    Dated: February 15, 2006.

    Jeffrey Shuren,

    Assistant Commissioner for Policy.

    End Signature Start Printed Page 9570

    Start Printed Page 9571

    Start Printed Page 9572

    Start Printed Page 9573

    Start Printed Page 9574

    Start Printed Page 9575

    Start Printed Page 9576

    Start Printed Page 9577

    Start Printed Page 9578

    Start Printed Page 9579

    Start Printed Page 9580

    Start Printed Page 9581

    Start Printed Page 9582

    Start Printed Page 9583

    Start Printed Page 9584

    Start Printed Page 9585

    End Supplemental Information

    [FR Doc. 06-1746 Filed 2-23-06; 8:45 am]

    BILLING CODE 4160-01-S

Document Information

Effective Date:
1/9/2006
Published:
02/24/2006
Department:
Food and Drug Administration
Entry Type:
Notice
Action:
Notice.
Document Number:
06-1746
Dates:
The agreement became effective January 9, 2006.
Pages:
9568-9585 (18 pages)
Docket Numbers:
FDA 225-05-3001
PDF File:
06-1746.pdf